HELIOS Kliniken

Survey on the working, training, and research conditions of resident physicians in internistic and rheumatological continuing education-BEWUSST. (2024) Proft F, Vossen D, Baraliakos X, Berliner MN, Fleck M, Keyßer G, Krause A, et al. Journal article Prehospital management of chest injuries in severely injured patients—a systematic review and clinical practice guideline update (2024) Waydhas C, Prediger B, Kamp O, Kleber C, Nohl A, Schulz-Drost S, Schreyer C, et al. Journal article, Review article Treatment strategy for severe implosion injuries of the lateral chest wall Versorgungsstrategie bei schweren Implosionsverletzungen der lateralen Thoraxwand (2024) Schulz-Drost S, Spering C Journal article, Review article Erste gemeinsame Doktorandentagung Klinische Pharmazie (2024) Wien K, Harjans A, Richter G, Berger V, Herrmann S, Schüling A, Michiel S, et al. Journal article Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024. (2024) Park-Simon TW, Müller V, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, Budach W, et al. Journal article, Review article Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients. (2024) Massa C, Karn T, Weber KE, Schneeweiss A, Hanusch C, Blohmer JU, Zahm DM, et al. Journal article, Letter Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial (2023) Koch R, Haveman L, Ladenstein R, Brichard B, Jürgens H, Cyprova S, van den Berg H, et al. Journal article Path to success: female leaders in German neurosurgery (2023) Weiss M, Dogan R, Eisenberg U, Velalakan A, Krüger J, Moritz I, Nistor-Gallo D, et al. Journal article Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy (2023) Huober J, van Mackelenbergh M, Schneeweiss A, Seither F, Blohmer JU, Denkert C, Tesch H, et al. Journal article RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial (2023) Link T, Blohmer JU, Schmitt WD, Kuhlmann JD, Just M, Untch M, Stoetzer OJ, et al. Journal article